VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
---|---|---|---|---|---|---|---|---|
TVIS30005896 | HIV | ENSG00000186642.16 | protein_coding | PDE2A | No | No | 5138 | O00408 Q8IW54 |
TVIS30005897 | HIV | ENSG00000186642.16 | protein_coding | PDE2A | No | No | 5138 | O00408 Q8IW54 |
TVIS30030686 | HIV | ENSG00000186642.16 | protein_coding | PDE2A | No | No | 5138 | O00408 Q8IW54 |
TVIS30030687 | HIV | ENSG00000186642.16 | protein_coding | PDE2A | No | No | 5138 | O00408 Q8IW54 |
TVIS44000482 | HTLV-1 | ENSG00000186642.16 | protein_coding | PDE2A | No | No | 5138 | O00408 Q8IW54 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
Gene | PDE2A |
---|---|
DrugBank ID | DB09273 |
Drug Name | Doxofylline |
Target ID | BE0002085 |
UniProt ID | O00408 |
Regulation Type | inhibitor |
PubMed IDs | 22138191 |
Citations | van Mastbergen J, Jolas T, Allegra L, Page CP: The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism. Pulm Pharmacol Ther. 2012 Feb;25(1):55-61. doi: 10.1016/j.pupt.2011.10.007. Epub 2011 Nov 25. |
Groups | Experimental |
Direct Classification | Xanthines |
SMILES | CN1C2=C(N(CC3OCCO3)C=N2)C(=O)N(C)C1=O |
Pathways | |
PharmGKB | |
ChEMBL | CHEMBL1527608 |